Robert Azelby
First SEC filing: Nov. 7, 2024 · Latest: March 18, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 29, 2026 | AUTL | A | 47,500 | · | · | 47,500 Direct | · | Acquired | (price as of 2026-10-02) |
| June 29, 2026 | AUTL | A | 31,667 | · | · | 31,667 Direct | · | Acquired | (price as of 2026-10-02) |
| June 19, 2026 | TNGX | A | 35,910 | · | · | 35,910 Direct | · | Acquired | (price as of 2026-10-02) |
| June 19, 2026 | TNGX | A | 5,740 | · | · | 5,740 Direct | · | Acquired | (price as of 2026-10-02) |
| June 3, 2026 | ADCT | F | 12,600 | $3.08 | $38,808 | 112,805 Direct | -10.05% | Disposed | -63.3% (price as of 2026-10-02) |
| June 1, 2026 | ADCT | A | 45,000 | · | · | 125,405 Direct | +55.97% | Acquired | (price as of 2026-10-02) |
| Nov. 5, 2025 | CAH | A | 1,067 | · | · | 4,085 Direct | +35.35% | Acquired | (price as of 2026-10-02) |
| June 13, 2025 | ADCT | F | 12,600 | $3.58 | $45,108 | 80,405 Direct | -13.55% | Disposed | -68.4% (price as of 2026-10-02) |
| June 3, 2025 | ADCT | A | 40,000 | · | · | 93,005 Direct | +75.46% | Acquired | (price as of 2026-10-02) |
| Nov. 6, 2024 | CAH | A | 1,730 | · | · | 3,018 Direct | +134.32% | Acquired | (price as of 2026-10-02) |
| June 17, 2024 | ADCT | S | 6,995 | $2.89 | $20,216 | 53,005 Direct | -11.66% | Disposed | -60.9% (price as of 2026-10-02) |
| June 13, 2024 | ADCT | A | 40,000 | · | · | 60,000 Direct | +200.00% | Acquired | (price as of 2026-10-02) |
| March 15, 2024 | CAH | A | 1,288 | · | · | 1,288 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 31, 2022 | CLYM | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2022 | CLYM | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 29, 2026 | AUTL | Share Option (Right to Buy) | American Depositary Shares | $1.61 | June 29, 2036 | 47,500 | Acquired |
| June 29, 2026 | AUTL | Restricted Share Units | American Depositary Shares | · | · | 31,667 | Acquired |
| June 19, 2026 | TNGX | Stock Option (Right to Buy) | Common Stock | $27.97 | June 19, 2036 | 35,910 | Acquired |
| Oct. 31, 2022 | CLYM | Stock Option (Right to Buy) | Common Stock | $3.27 | Oct. 30, 2032 | 500,000 | Acquired |
| Jan. 27, 2022 | CLYM | Stock Option (Right to Buy) | Common Stock | $8.21 | Jan. 26, 2032 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 18, 2026 | AUTL | Share Option (right to buy) | 80,000 | Direct |
| March 18, 2026 | AUTL | Share Option (right to buy) | 80,000 | Direct |
| March 18, 2026 | AUTL | Share Option (right to buy) | 80,000 | Direct |
| Jan. 2, 2024 | ADCT | Common Shares | · | Direct |
| Jan. 2, 2024 | ADCT | Stock Options (Right to Buy) | 31,000 | Direct |
| Aug. 9, 2021 | CLYM | Stock Option (Right to Buy) | 783,968 | Direct |
| Aug. 9, 2021 | CLYM | Stock Option (Right to Buy) | 406,494 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $675,000 | $438,750 | · | $4,035,050 | · | · | $12,200 | $5,161,000 |
| 2021 | $600,000 | $330,000 | · | $6,213,187 | · | · | $11,600 | $7,154,787 |
| 2020 | $150,000 | $75,000 | · | · | · | · | $3,000 | $228,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.